Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Cash & Equivalents (2016 - 2025)

Harte Hanks has reported Cash & Equivalents over the past 16 years, most recently at $5.6 million for Q4 2025.

  • Quarterly Cash & Equivalents fell 43.76% to $5.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.6 million through Dec 2025, down 43.76% year-over-year, with the annual reading at $5.6 million for FY2025, 43.76% down from the prior year.
  • Cash & Equivalents was $5.6 million for Q4 2025 at Harte Hanks, down from $6.5 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $26.5 million in Q1 2021 and troughed at $4.8 million in Q2 2025.
  • The 5-year median for Cash & Equivalents is $10.8 million (2022), against an average of $11.3 million.
  • Year-over-year, Cash & Equivalents plummeted 67.31% in 2021 and then surged 92.38% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $11.9 million in 2021, then decreased by 12.99% to $10.4 million in 2022, then skyrocketed by 82.01% to $18.9 million in 2023, then plummeted by 47.34% to $9.9 million in 2024, then tumbled by 43.76% to $5.6 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Cash & Equivalents are $5.6 million (Q4 2025), $6.5 million (Q3 2025), and $4.8 million (Q2 2025).